Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Synopsys stock
Learn how to easily invest in Synopsys stock.
Synopsys is a software-infrastructure business based in the US. Synopsys shares (SNPS) are listed on the NASDAQ and all prices are listed in US Dollars. Synopsys employs 19,000 staff and has a trailing 12-month revenue of around $5.3 billion.
How to buy Synopsys stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – SNPS. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 in stock when you fund a new account within 30 days
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
- Commission-free stock and ETF trades
- No management fees
- Customizable portfolios with automatic rebalancing
Synopsys stock price (NASDAQ: SNPS)Use our graph to track the performance of SNPS stocks over time.
Synopsys shares at a glance
|Latest market close||$435.32|
|52-week range||$267.00 - $468.03|
|50-day moving average||$386.64|
|200-day moving average||$346.12|
|Wall St. target price||$438.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$5.84|
Buy Synopsys stock from these online trading platformsCompare special offers, low fees and a wide range of investment options among top trading platforms.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is it a good time to buy Synopsys stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Synopsys price performance over time
Historical closes compared with the close of $435.32 from 2023-06-07
|1 week (2023-06-01)||-4.23%|
|1 month (2023-05-08)||17.10%|
|3 months (2023-03-08)||17.97%|
|6 months (2022-12-08)||31.67%|
|1 year (2022-06-08)||34.82%|
|2 years (2021-06-04)||N/A|
|3 years (2020-06-08)||133.02%|
|5 years (2018-06-08)||380.96%|
Is Synopsys stock undervalued or overvalued?
Valuing Synopsys stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Synopsys's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Synopsys's P/E ratio
Synopsys's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 77x. In other words, Synopsys shares trade at around 77x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Synopsys's PEG ratio
Synopsys's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.8459. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Synopsys's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Synopsys's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.2 billion.
The EBITDA is a measure of a Synopsys's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$5.3 billion|
|Operating margin TTM||19.66%|
|Gross profit TTM||$4.1 billion|
|Return on assets TTM||6.84%|
|Return on equity TTM||15.85%|
|Market capitalisation||$68.4 billion|
TTM: trailing 12 months
Synopsys share dividends
We're not expecting Synopsys to pay a dividend over the next 12 months.
Have Synopsys's shares ever split?
Synopsys's shares were split on a 2:1 basis on 24 September 2003. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Synopsys shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Synopsys shares which in turn could have impacted Synopsys's share price.
Synopsys share price volatility
Over the last 12 months, Synopsys's shares have ranged in value from as little as $267 up to $468.03. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Synopsys's is 1.1773. This would suggest that Synopsys's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Synopsys, Inc. provides electronic design automation software products used to design and test integrated circuits. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions. It also provides intellectual property (IP) solutions for USB, PCI Express, DDR, Ethernet, MIPI, HDMI, and Bluetooth low energy applications; logic libraries and embedded memories; processor cores, software, and application-specific instruction-set processor tools for embedded applications; security IP solutions; IP solutions for automotive market; and system-on-chip (SoC) infrastructure IP, datapath and building block IP, and verification IP products, as well as mathematical and floating-point components, and Arm AMBA interconnect fabric and peripherals. In addition, the company offers HAPS FPGA-based prototyping systems; virtual prototyping solutions; and Platform Architect solutions for SoC architecture analysis and optimization, as well as a series of tools used in the design of optical systems and photonic devices. Further, it provides security testing, managed services, programs and professional services, and training that enable its customers to detect and remediate security vulnerabilities, and defects in the software development lifecycle, as well as manufacturing solutions. The company serves electronics, financial services, automotive, medicine, energy, and industrial areas.
Synopsys in the news
Will ChatGPT Disrupt Wall Street Algos?
If You Invested $1000 in Synopsys a Decade Ago, This is How Much It'd Be Worth Now
Are Computer and Technology Stocks Lagging ServiceNow (NOW) This Year?
Frequently asked questionsWhat percentage of Synopsys is owned by insiders or institutions?
Currently 0.599% of Synopsys shares are held by insiders and 95.104% by institutions. How many people work for Synopsys?
Latest data suggests 19,000 work at Synopsys. When does the fiscal year end for Synopsys?
Synopsys's fiscal year ends in October. Where is Synopsys based?
Synopsys's address is: 690 East Middlefield Road, Mountain View, CA, United States, 94043 What is Synopsys's ISIN number?
Synopsys's international securities identification number is: US8716071076 What is Synopsys's CUSIP number?
Synopsys's Committee on Uniform Securities Identification Procedures number is: 871607107
More guides on Finder
JP Morgan Personal Advisors review 2023
Access remote advice, planning and portfolio management from this established financial services company.
How to buy Energy Transfer Equity stock
Steps to owning and managing ET, with 24-hour and historical pricing before you buy.
How to buy Uranium Energy stock
Steps to owning and managing UEC, with 24-hour and historical pricing before you buy.
How to buy Gold Royalty stock
Steps to owning and managing GROY, with 24-hour and historical pricing before you buy.
What happens if a brokerage firm fails?
Here’s what happens to your securities if your brokerage fails, and how your assets are protected by SIPC and FDIC.
Best online brokers & platforms to buy gold stocks in June 2023
Learn about buying physical gold, plus stocks and ETFs, to learn how you can add gold exposure to your portfolio.
Silicon Valley Bank collapse: Which ETFs and stocks are impacted?
Several ETFs have exposure to Silicon Valley Bank, but it appears minimal.
How to buy Treasury Bills
Treasury Bills are fixed-income assets with maturities of less than one year. Here’s what to know before investing.
SVB collapses: What does it mean for your portfolio?
The 16th largest US bank has collapsed, but its impact on your portfolio could be limited depending on what you own.
How to buy Vanguard VTI Total Stock Market ETF units
Steps to investing in the Vanguard (VTI) Total Stock Market ETF.
Ask an Expert